Alkem Laboratories on Friday denied claims that batches of its products Pan-D and Clavam 625 are not-of-standard quality (NSQ). This clarification by the company comes following central drug ...

NEW DELHI: Alkem Laboratories denied allegations on Friday that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards as reported by Central Drugs Standard Control ...

BENGALURU, Sept 27 (Reuters) - India's Alkem Laboratories (ALKE.NS), opens new tab on Friday denied claims that batches of its products, Pan-D and Clavam 625, are not of standard quality as the ...

The list has revealed that Pharma firm Alkem Health Science’s antibiotic drugs Clavam 625 and Pan D have been found spurious. (Image Credits: Pixabay) After the Central Drugs Standard Control ...

Researchers have synthesized drug-modified gold nanoparticles that can slowly release a commercially available antibiotic called clavam 1. The slow drug release is enough to kill disease causing ...

Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in question ...